Skip to content

Clinical Study on Chinese Children's Asthma Action Plan

Clinical Study on Chinese Children's Asthma Action Plan

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03435822
Enrollment
400
Registered
2018-02-19
Start date
2018-03-22
Completion date
2019-06-30
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma in Children

Keywords

asthma, children, action plan, China, CCAAP

Brief summary

This study is a multi-center randomized controlled trial of children with asthma. The objective of the study is to assess the efficacy of China Children Asthma Action Plan (CCAAP), which is the first asthma action plan for children with asthma in China, in asthma management.

Detailed description

Asthma is the most common chronic illness of childhood. Asthma action plans have been recommended internationally for more than 20 years by the Global Initiative for Asthma and have been shown to improve asthma-related outcomes. The first asthma action plan for children with asthma in China, which is termed China Children Asthma Action Plan(CCAAP), as well as a mobile phone-based asthma self management application(APP), were developed recently. The objective of the study is to assess the efficacy of CCAAP in asthma management. The study is a multi-center prospective case-controlled study.The enrollment period is 3 months. Patients who is in 6-14 years of age will be randomized recruited into two groups: the asthma action plan group and the conventional group. Patients in asthma action plan group will receive written CCAAP and mobile phone-based asthma self-management APP (Youran Respiratory) which includes an electronic asthma action plan, peak expiratory flow monitor system and Peak Expiratory Flow Meter. Patients in conventional management group will write down the symptoms and PEF in asthma diary. The data of the number of asthma episodes, the improvement of FEV1 , the number of unscheduled medical visits, the score of children's quality of life, the questionnaire of asthma knowledge, ACT / C-ACT score, the absent days of parental work, the absent days of children study, and the cost of health economics will be collected regularly in a year with the interval of 3 months to assess the efficacy of CCAAP in asthma management. The study will recruit 200 cases for each group from ten children's hospitals. The study will be completed in a year.

Interventions

OTHERasthma action plan management group

Patients will follow the directions in asthma action plan when their asthma get worse.

Patients will follow the directions in conventional strategy when their asthma get worse.

Sponsors

Tian Jing Children's Hospital
CollaboratorUNKNOWN
Capital Institute of Pediatrics, China
CollaboratorOTHER
Peking University Third Hospital
CollaboratorOTHER
Beijing Tsinghua Chang Gung Hospital
CollaboratorOTHER
Tianjin Medical University Second Hospital
CollaboratorOTHER
Peking University Bin Hai Hospital
CollaboratorUNKNOWN
The First Hospital of Qinhuangdao
CollaboratorOTHER_GOV
Tangshan Maternal and Child Health Hospital
CollaboratorOTHER
Children's Hospital of Hebei Province
CollaboratorOTHER
Beijing Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* did not receive control treatment or did not reach well-control; * can perform spirometry pulmonary function tests; * parents are skilled in using smartphones and APP apps (Android or IOS).

Exclusion criteria

* reach the level of asthma control; * can not use the smartphone APP software; * can not cooperate the test of peak expiratory flow; * did not treatment coexist respiratory disease effectively (such as sinusitis, obstructive sleep apnea-hypopnea syndrome, etc.); * combined with other systemic diseases outside the respiratory system (such as leukemia, rheumatoid arthritis, etc.). * receiving allergen-specific immunotherapy. * undergoing trial for other medications or instruments.

Design outcomes

Primary

MeasureTime frameDescription
number of acute episodes of asthma1 yearnumber of acute episodes of asthma in a year

Secondary

MeasureTime frameDescription
the changes of FEV1 before and after management1 yearthe changes of FEV1 before and after management in a year
the score of children's quality of life1 yearpediatric asthma quality of life questionnaire contains 23 items in three domains, activity limitation(10), symptoms(5) and emotional function(8). The scale from 1-7 for each question. And the higher score the better quality of life.
asthma knowledge1 yearKnowledge, attitude and practice(KAP) questionnaire,contains 27 questions. Multivariate analysis will be carry out based on the answers to questions
ACT / C-ACT score1 yearthe change of ACT / C-ACT score. there are 5 questions. For each questions, score ranks from 1 to five. Total score 25: well control, 20\ 24: control, less than 20: un ncontrol
the absent days of school1 yearthe number of absent days of school because of asthma attack
the absent days of parents' work1 yearthe number of absent days of parents' work because of children's asthma attack
the cost of health economics1 yearthe cost of acute asthma exacerbation in a year
the number of unscheduled medical care1 yearthe number of unscheduled medical care in a year

Contacts

Primary ContactKunling Shen, MD,PhD
kunlingshen1717@163.com59616666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026